Equities

Dynatronics Corp

DYNT:NAQ

Dynatronics Corp

Actions
Health CareMedical Equipment and Services
  • Price (USD)0.3901
  • Today's Change0.000 / 0.03%
  • Shares traded5.34k
  • 1 Year change-52.43%
  • Beta0.3224
Data delayed at least 15 minutes, as of May 24 2024 15:04 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Dynatronics Corporation is a medical device company engaged in providing restorative products designed to accelerate achieving optimal health. The Company designs, manufactures, and sells a range of products for clinical use in physical therapy, rehabilitation, orthopedics, pain management, and athletic training. Through its distribution channels, the Company markets and sells to orthopedists, physical therapists, chiropractors, athletic trainers, sports medicine practitioners, clinics, and hospitals. The Company's products are marketed under a portfolio of brands, including Bird & Cronin, Solaris, Hausmann, PROTEAM, and Mammoth, among others. Its orthopedic soft bracing products are designed to accelerate health for patients both pre- and post-surgical intervention, and during fracture recovery, joint stabilization, and ligament injury. The Company’s Solaris, Hausmann, PROTEAM, and Mammoth brands include products for physical therapy, rehabilitation, and athletic training.

  • Revenue in USD (TTM)33.60m
  • Net income in USD-5.14m
  • Incorporated1983
  • Employees154.00
  • Location
    Dynatronics CorpBLDG D, 7030 PARK CENTRE DRIVESALT LAKE CITY 84121United StatesUSA
  • Phone+1 (801) 568-7000
  • Fax+1 (801) 568-7711
  • Websitehttps://www.dynatronics.com
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
SPO Global Inc838.00k-540.00k1.25m2.00------1.49-85.99-85.99131.76-476.561.76-------113.56-305.39----31.1527.31-64.44-384.85---1.45-----17.09-15.1313.03------
Escalon Medical Corp11.65m-296.71k1.30m38.00--1.26--0.1114-0.0401-0.04011.290.22592.403.757.51306,456.30-1.26-1.76-2.84-3.6744.0744.57-0.5265-0.91140.8927-1.620.1584--13.801.33760.89-17.06-19.85--
Nemaura Medical Inc0.00-10.65m1.45m36.00---------0.3787-0.37870.00-0.61690.000.00--0.00-117.49-58.18---131.96-------7,384.830.0305-1.4710.81---84.71---1.85--64.14--
Grapefruit USA Inc34.85k-4.37m1.55m9.00------44.46-0.008-0.0080.00006-0.01010.01211.310.22593,872.22-151.85-268.93-----1,304.65-10.09-12,531.68-408.870.0388-1.50-----83.9677.87-35.68------
Acutus Medical Inc7.16m-11.92m1.57m233.00------0.2189-0.4097-0.4170.2467-0.03080.07651.170.441730,746.78-12.72-46.76-16.05-56.88-43.79-89.12-166.40-773.492.22-6.781.03--136.3627.03-141.35---35.99--
Bone Biologics Corp0.00-6.10m1.66m2.00--0.4177-----23.10-23.100.003.620.00----0.00-114.93-98.31-189.37--------------0.00-------502.76------
Kelyniam Global Inc517.70k-420.28k1.80m0.00--3.36--3.47-0.0253-0.02530.03120.01790.41357.044.38---33.57---41.79--18.86---81.18--1.26--0.6232---26.47---19.10------
Aethlon Medical, Inc.574.25k-12.26m2.07m15.00--0.1399--3.60-5.03-5.030.23622.930.0369----38,283.33-78.62-75.30-92.02-84.98-----2,133.17-1,783.78----0.00--95.2130.86-15.55--106.99--
Dynatronics Corp33.60m-5.14m2.07m154.00--0.2774--0.0616-1.19-1.197.583.041.103.338.31218,173.30-14.35-6.02-19.94-8.3021.3727.33-13.07-4.550.6787-12.560.2188---8.41-8.81-19.84---5.11--
NanoVibronix Inc2.85m-3.20m2.07m10.00--0.592--0.7278-1.72-1.721.451.260.5160.368313.64285,000.00-57.98-116.16-101.17-169.3668.9850.47-112.35-570.471.38-13.470.00--203.5948.3331.88---34.02--
VirExit Technologies Inc0.00-1.80m2.28m-----------0.0932-0.1130.00-0.03670.00-------6,103.43-----------------3.66-----100.00--19.08------
Bioelectronics Corp1.61m-289.82k2.47m9.00------1.53-0.00002-0.000020.00007-0.00066.329.2014.53---113.86-383.59----49.4351.48-18.01-143.480.0099-0.4909----94.01-5.0975.01------
Tivic Health Systems Inc1.23m-8.26m2.54m16.00--0.1043--2.07-42.45-42.452.753.930.16131.0710.8676,687.50-108.51---135.42--26.49---672.78--5.53--0.00--46.38---18.86------
InnerScope Hearing Technologies, Inc.334.45k-7.15m2.57m24.00------7.68-0.0153-0.01530.0002-0.00280.09553.931.71---204.11-27.82---94.5317.7958.17-2,138.50-42.130.0022-0.4232------100.59----233.50--
Tenon Medical Inc3.21m-14.33m2.79m21.00--8.61--0.8683-7.24-7.241.430.97240.41082.787.25153,047.60-183.10---269.43--54.70---445.77--2.35--0.00--323.73--17.63------
Data as of May 24 2024. Currency figures normalised to Dynatronics Corp's reporting currency: US Dollar USD

Institutional shareholders

3.63%Per cent of shares held by top holders
HolderShares% Held
Renaissance Technologies LLCas of 31 Mar 2024134.82k2.76%
Albion Management Group Ltd.as of 31 Mar 202418.00k0.37%
The Vanguard Group, Inc.as of 31 Mar 202416.07k0.33%
Tower Research Capital LLCas of 31 Mar 20244.42k0.09%
BlackRock Fund Advisorsas of 31 Mar 20243.23k0.07%
Sunbelt Securities, Inc.as of 31 Mar 2024500.000.01%
UBS Securities LLCas of 31 Mar 2024107.000.00%
Morgan Stanley Smith Barney LLC (Investment Management)as of 31 Mar 202440.000.00%
Wells Fargo Bank, NA (Private Banking)as of 31 Mar 202423.000.00%
G1 Execution Services LLCas of 31 Mar 20240.000.00%
More ▼
Data from 31 Mar 2024 - 31 Mar 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.